Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy E Corcoran

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 11, 2019
Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic EffectTimothy E Corcoran, Alex S Huber, Michael M Myerburg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2021
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-studyScott H Donaldson, Beth L Laube, Peter Mogayzel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 14, 2024
The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC StudyScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 14, 2020
Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in MedicineJames B Fink, Stephan Ehrmann, Jie Li, et al.
ERJ Open Research|January 19, 2023
Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic responseTimothy E Corcoran, Carol A Bertrand, Michael M Myerburg, et al.
JCI Insight|December 21, 2018
Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTRScott H Donaldson, Beth L Laube, Timothy E Corcoran, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 16, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosisScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
The New England Journal of Medicine|January 13, 2006
A randomized trial of inhaled cyclosporine in lung-transplant recipientsAldo T Iacono, Bruce A Johnson, Wayne F Grgurich, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 11, 2019
Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic EffectTimothy E Corcoran, Alex S Huber, Michael M Myerburg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2021
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-studyScott H Donaldson, Beth L Laube, Peter Mogayzel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 14, 2024
The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC StudyScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 14, 2020
Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in MedicineJames B Fink, Stephan Ehrmann, Jie Li, et al.
ERJ Open Research|January 19, 2023
Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic responseTimothy E Corcoran, Carol A Bertrand, Michael M Myerburg, et al.
JCI Insight|December 21, 2018
Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTRScott H Donaldson, Beth L Laube, Timothy E Corcoran, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 16, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosisScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
The New England Journal of Medicine|January 13, 2006
A randomized trial of inhaled cyclosporine in lung-transplant recipientsAldo T Iacono, Bruce A Johnson, Wayne F Grgurich, et al.
Pageof 6